Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief …
Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development today announced that the European Medicines Agency (EMA) has …
SHANGHAI, May 9, 2022 /PRNewswire/ — OBiO Technology (Shanghai) Corp., Ltd. (‘OBiO’, SSE:688238.SH), a gene and cell therapy-focused biotechnology company, …
HUDDINGE, Sweden, May 5, 2022 /PRNewswire/ — Medivir Aktiebolag (publ) held its annual shareholders’ meeting today on 5 May 2022. …
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2022 and reiterated …
CAMBRIDGE, Mass., March 24, 2022 /PRNewswire/ — Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies designed to modulate RNA …
SAN FRANCISCO, March 24, 2022 /PRNewswire/ — Kim Meredith, CEO of the San Francisco General Hospital (SFGH) Foundation, has joined …
KAHR, a clinical stage cancer immunotherapy company developing novel dual-targeting protein therapeutics, today announced publication of preclinical data supporting the development of …
Kintara Therapeutics, Inc., a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announces that it …
Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness …
